Opportunities

Opportunities

Funding Opportunity

GIZ Call for Proposals – Facilitation of Knowledge Exchange, Partnerships and Investment Linkages between Europe and South Africa

Organisation: GIZ
Application deadline: 20 July 2026

Category

Proposal Call

Topics

Trade & Investment Other Entrepreneurship

Description

Reference Number: 7000016307)

Project Background

The SAVax (Vaccines for Africa: Roll out and Production in South Africa) programme supports South Africa’s ambition to strengthen local production of vaccines, medicines, and other health technologies. The programme is co-financed by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU).

As part of this initiative, GIZ is seeking a service provider to facilitate knowledge exchange, strategic partnerships, and investment linkages between Europe and South Africa. The assignment aims to strengthen collaboration among public institutions, industry, investors, research organisations, and other stakeholders to enhance South Africa’s vaccine manufacturing ecosystem and broader health technology sector.

Main Objective

The selected contractor will support the development of sustainable partnerships and investment opportunities by facilitating collaboration and knowledge transfer between European and South African stakeholders involved in vaccine production and health innovation.

Expected Activities (subject to the full Terms of Reference)

The assignment is expected to include activities such as:

  • Facilitating knowledge exchange between European and South African organisations working in vaccine manufacturing and health technologies.
  • Identifying and connecting potential industry, research, and investment partners.
  • Supporting business matchmaking and partnership development.
  • Organising networking events, workshops, study visits, or investment dialogues.
  • Promoting collaboration that strengthens local manufacturing capacity and technology transfer.
  • Supporting investment linkages that contribute to sustainable growth of the vaccine and health technology ecosystem.

Target Stakeholders

The assignment is expected to engage stakeholders such as:

  • Vaccine and pharmaceutical manufacturers
  • Health technology companies
  • Research institutions and universities
  • Investors and development finance institutions
  • Government agencies
  • European and South African industry partners
  • Innovation and technology organisations

Indicative Deliverables

While the detailed outputs are specified in the Terms of Reference, deliverables are likely to include:

  • Stakeholder mapping and engagement
  • Partnership facilitation and matchmaking activities
  • Knowledge exchange events and workshops
  • Investment promotion activities
  • Reports documenting activities, partnerships, and outcomes

Eligibility

Interested organisations should consult the application documents for the detailed eligibility requirements. The opportunity is primarily suited to organisations with demonstrated experience in areas such as:

  • International partnership facilitation
  • Investment promotion
  • Health innovation ecosystems
  • Pharmaceutical or vaccine value chains
  • Business development and stakeholder engagement
  • Project management in international development programmes

Application Documents

Applicants should review the complete tender package, including:

  • Invitation Letter
  • Application Document
  • Terms of Reference (TOR)
  • Technical Assessment
  • Eligibility Assessment Grid
  • Self-Declaration Form
  • General Terms and Conditions
  • Price Schedule

These documents contain the detailed scope of work, evaluation methodology, contractual conditions, and submission requirements.

Website

https://www.giz.de/en/call-proposals-7000016307-facilitation-knowledge-exchange-partnerships-and-investment-linkages
Funding

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.